Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • NEWS

‘Killer’ immune cells still recognize Omicron variant

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Nature 601, 307 (2022)

doi: https://doi.org/10.1038/d41586-022-00063-0

References

  1. May, D. H. et al. Preprint at medRxiv https://doi.org/10.1101/2021.12.20.21267877 (2021).

  2. Keeton, R. et al. Preprint at medRxiv https://doi.org/10.1101/2021.12.26.21268380 (2021).

  3. Geurts van Kessel, C. H. et al. Preprint at medRxiv https://doi.org/10.1101/2021.12.27.21268416 (2021).

  4. Liu, J. et al. Preprint at medRxiv https://doi.org/10.1101/2022.01.02.22268634 (2022).

  5. Collie, S., Champion, J., Moultrie, H., Bekker, L.-G. & Gray, G. N. Engl. J. Med. https://doi.org/10.1056/NEJMc2119270 (2021).

    Article  Google Scholar 

  6. Gray, G. E. et al. Preprint at medRxiv https://doi.org/10.1101/2021.12.28.21268436 (2021).

Download references

Subjects

Latest on:

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Quick links